# days | Task | Group I Age: 9.1 (8.2–10.3) |
Group II Age: 9.4 (8.0–11.2) |
Group III Age: 9.2 (7.8–11.1) |
|
---|---|---|---|---|---|
Baseline | 15 | DNMP | N=4M/6F placebo |
N=2M/8F placebo |
N=3M/7F placebo |
14 day Wash-in | |||||
Single Supplement Phase | 129 | Landmark | N=4M/6F placebo |
N=2M/8F 11mg/kg LA |
N=3M/7F 27.5mg/kg ALCAR |
14 day Wash-in | |||||
Combined Supplement Phase | 79 | Black/white Discrimination & Reversal | N=4M/6F placebo |
N=2M/8F 11mg/kg LA +27.5mg/kg ALCAR |
N=3M/7F 27.5mg/kg ALCAR +11mg/kg LA |
14 day Wash-out | |||||
Wash-out Phase | 50 | Size Discrimination & Reversal | N=4M/6F placebo |
N=2M/8F placebo |
N=2M/7F placebo |